-
1 Comment
3SBio Inc is currently in a long term uptrend where the price is trading 11.6% above its 200 day moving average.
From a valuation standpoint, the stock is 97.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.9.
3SBio Inc's total revenue rose by 8.1% to $3B since the same quarter in the previous year.
Its net income has dropped by 79.6% to $133M since the same quarter in the previous year.
Finally, its free cash flow grew by 229.0% to $354M since the same quarter in the previous year.
Based on the above factors, 3SBio Inc gets an overall score of 4/5.
| Exchange | HK |
|---|---|
| CurrencyCode | HKD |
| Sector | Healthcare |
| Industry | Biotechnology |
| ISIN | KYG8875G1029 |
| Beta | 0.67 |
|---|---|
| Market Cap | 28B |
| PE Ratio | 13.27 |
| Target Price | 12.1982 |
| Dividend Yield | 2.1% |
3SBio Inc., an investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally. The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thrombocytopenia; and Cipterbin, an anti-HER2 monoclonal antibody for the treatment of advanced HER2-positive breast cancer and pan-HER2. It also offers Yisaipu, the receptor fusion tumor necrosis factor inhibitor; EPIAO and SEPO, an erythropoietin injection; Mandi-minoxidil, an OTC external medicine for treating hair loss; and SPARIN, an injectable low-molecular-weight heparin calcium. In addition, the company provides Remitch, a nalfuraphine hydrochloride orally disintegrating tablets; MN709, a minoxidil foam formulation for the treatment of androgenetic alopecia and alopecia areata; and other products in the areas of nephrology, hematology, oncology, auto-immune, ophthalmology, and dermatology and metabolism. Further, it engages in trading; research and development of biotechnology and drugs; sells chemical products; and retail of pharmaceuticals. Additionally, the company provides project management and consultation, technology, sports, financial, clinic, investment advisory, and agricultural services, as well as manufactures medical devices. 3SBio Inc. was founded in 1993 and is headquartered in Shenyang, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 1530.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
